Economic portfolio
TATA NIFTY MIDSMALL HEALTHCARE INDEX FUND
TATA Tata Mutual Fund Apr 2024 — Sep 2026 29 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 0.3 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
29 priced months, Apr 2024 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
58.7% now, 57.8% in Sep 2025 · highest 62.4%, lowest 57.8%
Companies held
30 now, 30 in Sep 2025 · largest single holding 11.8% of equity
How it trades: no clear lean toward recent winners or losers (score -0.01 over 27 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- Motilal Oswal Nifty MidSmall Healthcare Index FundMotilal Oswal · 30 shared100.0%
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 30 shared48.4%
- Mirae Asset Healthcare FundMirae Asset · 17 shared47.6%
- Baroda BNP Paribas Health and Wellness FundBaroda BNP Paribas · 15 shared44.0%
- Nippon India Nifty Pharma ETFNippon India · 14 shared43.1%
- ICICI Prudential Nifty Pharma Index FundICICI Prudential · 14 shared43.1%
- Bandhan BSE Healthcare Index FundBandhan · 30 shared40.8%
- Motilal Oswal BSE Healthcare ETFMotilal Oswal · 30 shared40.8%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
Complete exits
Largest increases
- 01 Aster DM Quality Care Limited+8.4% +6,990
- 02 Piramal Pharma Limited+2.5% +5,153
- 03 Krishna Institute of Medical Sciences Limited+5.7% +4,844
- 04 Fortis Healthcare Limited+2.6% +4,521
- 05 Laurus Labs Limited+2.7% +3,525
- 06 Aurobindo Pharma Limited+2.5% +2,267
- 07 Lupin Limited+2.7% +2,136
- 08 Granules India Limited+4.3% +2,065
- 09 Global Health Limited+6.2% +1,763
- 10 Syngene International Limited+2.5% +1,578
Largest reductions
- None this month.
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Laurus Labs Limited | Healthcare | Mid Cap | 11.82% | 26.12 Cr | 0.01 Cr | by Apr 2024 (29 mo+) |
| Lupin Limited | Healthcare | Mid Cap | 7.56% | 16.70 Cr | 82,281 | by Apr 2024 (29 mo+) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 7.08% | 15.65 Cr | 93,615 | by Apr 2024 (29 mo+) |
| Fortis Healthcare Limited | Healthcare | Mid Cap | 6.15% | 13.59 Cr | 0.02 Cr | by Apr 2024 (29 mo+) |
| Glenmark Pharmaceuticals Limited | Healthcare | Mid Cap | 5.39% | 11.91 Cr | 51,001 | by Apr 2024 (29 mo+) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 4.77% | 10.55 Cr | 20,425 | by Apr 2024 (29 mo+) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 4.35% | 9.61 Cr | 38,387 | by Apr 2024 (29 mo+) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 4.10% | 9.07 Cr | 47,059 | by Apr 2024 (29 mo+) |
| Biocon Limited | Healthcare | Mid Cap | 3.96% | 8.74 Cr | 0.02 Cr | by Apr 2024 (29 mo+) |
| Gland Pharma Limited | Healthcare | Small Cap | 3.54% | 7.83 Cr | 26,996 | by Apr 2024 (29 mo+) |
| Sai Life Sciences Limited | Healthcare | Small Cap | 3.23% | 7.14 Cr | 46,851 | Mar 2026 (7 mo) |
| Krishna Institute of Medical Sciences Limited | Healthcare | Small Cap | 3.05% | 6.75 Cr | 90,397 | by Apr 2024 (29 mo+) |
| Aster DM Quality Care Limited | Healthcare | Small Cap | 2.86% | 6.31 Cr | 90,546 | by Apr 2024 (29 mo+) |
| Neuland Laboratories Limited | Healthcare | Small Cap | 2.82% | 6.24 Cr | 2,921 | Mar 2025 (19 mo) |
| Wockhardt Limited | Healthcare | Small Cap | 2.68% | 5.92 Cr | 27,982 | Sep 2025 (13 mo) |
| Acutaas Chemicals Limited | Healthcare | Small Cap | 2.61% | 5.76 Cr | 17,578 | Jul 2026 (3 mo) |
| Ajanta Pharma Limited | Healthcare | Small Cap | 2.53% | 5.59 Cr | 15,443 | by Apr 2024 (29 mo+) |
| Dr. Lal Path Labs Ltd. | Healthcare | Small Cap | 2.38% | 5.25 Cr | 26,429 | by Apr 2024 (29 mo+) |
| Abbott India Limited | Healthcare | Mid Cap | 2.17% | 4.79 Cr | 1,765 | by Apr 2024 (29 mo+) |
| Piramal Pharma Limited | Healthcare | Small Cap | 1.97% | 4.35 Cr | 0.02 Cr | by Apr 2024 (29 mo+) |
| Granules India Limited | Healthcare | Small Cap | 1.91% | 4.23 Cr | 49,956 | by Apr 2024 (29 mo+) |
| Narayana Hrudayalaya Ltd. | Healthcare | Mid Cap | 1.90% | 4.19 Cr | 23,401 | by Apr 2024 (29 mo+) |
| Global Health Limited | Healthcare | Mid Cap | 1.85% | 4.10 Cr | 30,022 | by Apr 2024 (29 mo+) |
| Onesource Specialty Pharma Limited | Healthcare | Small Cap | 1.84% | 4.06 Cr | 26,663 | Sep 2025 (13 mo) |
| GlaxoSmithKline Pharmaceuticals Limited | Healthcare | Mid Cap | 1.76% | 3.88 Cr | 14,024 | by Apr 2024 (29 mo+) |
| Anthem Biosciences Limited | Healthcare | Mid Cap | 1.42% | 3.14 Cr | 36,551 | Sep 2026 (1 mo) |
| Natco Pharma Limited | Healthcare | Small Cap | 1.14% | 2.52 Cr | 30,435 | by Apr 2024 (29 mo+) |
| Cohance Lifesciences Limited | Healthcare | Small Cap | 1.11% | 2.45 Cr | 55,110 | by Apr 2024 (29 mo+) |
| Syngene International Limited | Healthcare | Small Cap | 1.06% | 2.35 Cr | 64,320 | by Apr 2024 (29 mo+) |
| Poly Medicure Limited | Healthcare | Small Cap | 0.98% | 2.16 Cr | 12,934 | by Apr 2024 (29 mo+) |
Half of its current holdings have been held for 29 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Anthem Biosciences Limited | Sep 2026 | ▲ New position | +36,551 |
| Aster DM Quality Care Limited | Sep 2026 | ▲ Increasing | +6,990 |
| Piramal Pharma Limited | Sep 2026 | ▲ Increasing | +5,153 |
| Pfizer Limited | Sep 2026 | ▼ Complete exit | -5,001 |
| Krishna Institute of Medical Sciences Limited | Sep 2026 | ▲ Increasing | +4,844 |
| Fortis Healthcare Limited | Sep 2026 | ▲ Increasing | +4,521 |
| Laurus Labs Limited | Sep 2026 | ▲ Increasing | +3,525 |
| Aurobindo Pharma Limited | Sep 2026 | ▲ Increasing | +2,267 |
| Lupin Limited | Sep 2026 | ▲ Increasing | +2,136 |
| Granules India Limited | Sep 2026 | ▲ Increasing | +2,065 |
| Global Health Limited | Sep 2026 | ▲ Increasing | +1,763 |
| Syngene International Limited | Sep 2026 | ▲ Increasing | +1,578 |
| Ajanta Pharma Limited | Sep 2026 | ▲ Increasing | +1,544 |
| Cohance Lifesciences Limited | Sep 2026 | ▲ Increasing | +1,415 |
| Sai Life Sciences Limited | Sep 2026 | ▲ Increasing | +1,318 |
| Glenmark Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +1,311 |
| IPCA Laboratories Limited | Sep 2026 | ▲ Increasing | +1,218 |
| Alkem Laboratories Limited | Sep 2026 | ▲ Increasing | +1,115 |
| Mankind Pharma Limited | Sep 2026 | ▲ Increasing | +1,025 |
| Natco Pharma Limited | Sep 2026 | ▲ Increasing | +785 |
| Wockhardt Limited | Sep 2026 | ▲ Increasing | +729 |
| Onesource Specialty Pharma Limited | Sep 2026 | ▲ Increasing | +711 |
| Dr. Lal Path Labs Ltd. | Sep 2026 | ▲ Increasing | +710 |
| Gland Pharma Limited | Sep 2026 | ▲ Increasing | +700 |
| Biocon Limited | Sep 2026 | ▲ Increasing | +625 |
| Narayana Hrudayalaya Ltd. | Sep 2026 | ▲ Increasing | +599 |
| Acutaas Chemicals Limited | Sep 2026 | ▲ Increasing | +463 |
| GlaxoSmithKline Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +365 |
| Poly Medicure Limited | Sep 2026 | ▲ Increasing | +329 |
| Neuland Laboratories Limited | Sep 2026 | ▲ Increasing | +75 |
| Abbott India Limited | Sep 2026 | ▲ Increasing | +46 |
| Biocon Limited | Aug 2026 | ▲ Increasing | +9,894 |
| Piramal Pharma Limited | Aug 2026 | ▲ Increasing | +8,625 |
| Fortis Healthcare Limited | Aug 2026 | ▲ Increasing | +7,227 |
| Laurus Labs Limited | Aug 2026 | ▲ Increasing | +5,396 |
| Aurobindo Pharma Limited | Aug 2026 | ▲ Increasing | +3,839 |
| Krishna Institute of Medical Sciences Limited | Aug 2026 | ▲ Increasing | +3,595 |
| Aster DM Quality Care Limited | Aug 2026 | ▲ Increasing | +3,511 |
| Lupin Limited | Aug 2026 | ▲ Increasing | +3,368 |
| Syngene International Limited | Aug 2026 | ▲ Increasing | +2,637 |
| Cohance Lifesciences Limited | Aug 2026 | ▲ Increasing | +2,256 |
| Glenmark Pharmaceuticals Limited | Aug 2026 | ▲ Increasing | +2,088 |
| Granules India Limited | Aug 2026 | ▲ Increasing | +2,012 |
| IPCA Laboratories Limited | Aug 2026 | ▲ Increasing | +1,926 |
| Sai Life Sciences Limited | Aug 2026 | ▲ Increasing | +1,913 |
| Mankind Pharma Limited | Aug 2026 | ▲ Increasing | +1,570 |
| Natco Pharma Limited | Aug 2026 | ▲ Increasing | +1,246 |
| Global Health Limited | Aug 2026 | ▲ Increasing | +1,188 |
| Wockhardt Limited | Aug 2026 | ▲ Increasing | +1,145 |
| Gland Pharma Limited | Aug 2026 | ▲ Increasing | +1,105 |
| Onesource Specialty Pharma Limited | Aug 2026 | ▲ Increasing | +1,090 |
| Dr. Lal Path Labs Ltd. | Aug 2026 | ▲ Increasing | +1,081 |
| Narayana Hrudayalaya Ltd. | Aug 2026 | ▲ Increasing | +958 |
| Alkem Laboratories Limited | Aug 2026 | ▲ Increasing | +811 |
| Acutaas Chemicals Limited | Aug 2026 | ▲ Increasing | +720 |
| Ajanta Pharma Limited | Aug 2026 | ▲ Increasing | +584 |
| GlaxoSmithKline Pharmaceuticals Limited | Aug 2026 | ▲ Increasing | +574 |
| Poly Medicure Limited | Aug 2026 | ▲ Increasing | +530 |
| Pfizer Limited | Aug 2026 | ▲ Increasing | +211 |
| Neuland Laboratories Limited | Aug 2026 | ▲ Increasing | +120 |
| Abbott India Limited | Aug 2026 | ▲ Increasing | +72 |
| J.B. Chemicals & Pharmaceuticals Lt | Jul 2026 | ▼ Complete exit | -23,634 |
| Biocon Limited | Jul 2026 | ▲ Increasing | +19,495 |
| Piramal Pharma Limited | Jul 2026 | ▲ Increasing | +17,730 |
| Acutaas Chemicals Limited | Jul 2026 | ▲ New position | +16,395 |
| Fortis Healthcare Limited | Jul 2026 | ▲ Increasing | +14,290 |
| Laurus Labs Limited | Jul 2026 | ▲ Increasing | +10,669 |
| Krishna Institute of Medical Sciences Limited | Jul 2026 | ▲ Increasing | +10,650 |
| Onesource Specialty Pharma Limited | Jul 2026 | ▲ Increasing | +8,925 |
| Aster DM Quality Care Limited | Jul 2026 | ▲ Increasing | +6,944 |
| Aurobindo Pharma Limited | Jul 2026 | ▲ Increasing | +6,801 |
| Lupin Limited | Jul 2026 | ▲ Increasing | +6,750 |
| Syngene International Limited | Jul 2026 | ▲ Increasing | +5,319 |
| Cohance Lifesciences Limited | Jul 2026 | ▲ Increasing | +4,462 |
| Glenmark Pharmaceuticals Limited | Jul 2026 | ▲ Increasing | +4,130 |
| Granules India Limited | Jul 2026 | ▲ Increasing | +3,980 |
| Sai Life Sciences Limited | Jul 2026 | ▲ Increasing | +3,892 |
| IPCA Laboratories Limited | Jul 2026 | ▲ Increasing | +3,816 |
| Mankind Pharma Limited | Jul 2026 | ▲ Increasing | +3,125 |
| Global Health Limited | Jul 2026 | ▲ Increasing | +2,628 |
| Natco Pharma Limited | Jul 2026 | ▲ Increasing | +2,503 |
| Wockhardt Limited | Jul 2026 | ▲ Increasing | +2,258 |
| Gland Pharma Limited | Jul 2026 | ▲ Increasing | +2,213 |
| Dr. Lal Path Labs Ltd. | Jul 2026 | ▲ Increasing | +2,149 |
| Narayana Hrudayalaya Ltd. | Jul 2026 | ▲ Increasing | +1,895 |
| Alkem Laboratories Limited | Jul 2026 | ▲ Increasing | +1,605 |
| Ajanta Pharma Limited | Jul 2026 | ▲ Increasing | +1,153 |
| GlaxoSmithKline Pharmaceuticals Limited | Jul 2026 | ▲ Increasing | +1,140 |
| Poly Medicure Limited | Jul 2026 | ▲ Increasing | +1,047 |
| Pfizer Limited | Jul 2026 | ▲ Increasing | +417 |
| Neuland Laboratories Limited | Jul 2026 | ▲ Increasing | +237 |
| Abbott India Limited | Jul 2026 | ▲ Increasing | +144 |
| Biocon Limited | Jun 2026 | ▲ Increasing | +369 |
| Piramal Pharma Limited | Jun 2026 | ▲ Increasing | +320 |
| Fortis Healthcare Limited | Jun 2026 | ▲ Increasing | +270 |
| Laurus Labs Limited | Jun 2026 | ▲ Increasing | +201 |
| Aurobindo Pharma Limited | Jun 2026 | ▲ Increasing | +144 |
| Aster DM Quality Care Limited | Jun 2026 | ▲ Increasing | +131 |
| Krishna Institute of Medical Sciences Limited | Jun 2026 | ▲ Increasing | +127 |
| Lupin Limited | Jun 2026 | ▲ Increasing | +126 |
Changes compare consecutive month-end disclosures for this portfolio only.